FOXO4-DRI is a synthetic peptide engineered to disrupt the interaction between FOXO4 and p53, a pathway associated with the survival of senescent (“aged” or dysfunctional) cells. In preclinical research, this disruption may allow targeted clearance of senescent cells by reactivating apoptosis.
Senescent cells are known to accumulate over time and contribute to chronic inflammation through the release of pro-inflammatory signaling molecules (often referred to as SASP—senescence-associated secretory phenotype). By selectively addressing these cells, FOXO4-DRI is being studied for its potential role in improving tissue function and cellular health.
Mechanisms of Action
- May disrupt FOXO4–p53 binding, promoting apoptosis in senescent cells
- May support senolytic activity, targeting aged or dysfunctional cells
- May reduce SASP-related inflammatory signaling, improving tissue environment
- May contribute to improved cellular turnover and regeneration conditions
- May help restore balance in aging or stressed tissues
All CNC Bio Labs products are for research use only — not for human or veterinary consumption. CNC Bio Labs does not endorse or make any medical claims regarding the use or effects of its products. By purchasing, you confirm and understand these products are not for medical use, and agree CNC Bio Labs is not liable for misuse or regulatory non-compliance.




Reviews
There are no reviews yet.